Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril + hydrochlorothiazide pill versus capsule in mild to moderate hypertension
ISRCTN05051235Phase 3Completed
- Sponsor
- Libbs Farmacêutica
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ramipril and hydrochlorothiazide in essential hypertension and hypertension (HTN) (2 arms), sponsored by Libbs Farmacêutica. Primary endpoint: Reduction in mean systolic and diastolic blood pressure by ABPM. Started Dec 2010; status: completed.
02
Drugs
ramiprilhydrochlorothiazide
03
Conditions
essential hypertensionhypertension (HTN)
Beyond the preview
Go deeper on ISRCTN05051235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN05051235.